BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12377246)

  • 1. Ten years of NGDO action against river blindness.
    Drameh PS; Richards FO; Cross C; Etya'alé DE; Kassalow JS
    Trends Parasitol; 2002 Sep; 18(9):378-80. PubMed ID: 12377246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. River blindness.
    Unnasch TR
    Lancet; 2002 Jul; 360(9328):182-3. PubMed ID: 12133647
    [No Abstract]   [Full Text] [Related]  

  • 3. Good news on a tropical disease.
    Kennedy D
    Science; 2002 May; 296(5572):1365. PubMed ID: 12029099
    [No Abstract]   [Full Text] [Related]  

  • 4. The Carter Center's assistance to river blindness control programs: establishing treatment objectives and goals for monitoring ivermectin delivery systems on two continents.
    Richards FO; Miri ES; Katabarwa M; Eyamba A; Sauerbrey M; Zea-Flores G; Korve K; Mathai W; Homeida MA; Mueller I; Hilyer E; Hopkins DR
    Am J Trop Med Hyg; 2001 Aug; 65(2):108-14. PubMed ID: 11508383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. River blindness elimination in Columbia.
    Burki T
    Lancet Infect Dis; 2013 Nov; 13(11):922-3. PubMed ID: 24319775
    [No Abstract]   [Full Text] [Related]  

  • 6. Onchocerciasis (river blindness). Report from the fifteenth InterAmerican Conference on Onchocerciasis, Caracas, Venezuela.
    Wkly Epidemiol Rec; 2006 Jul; 81(30):293-6. PubMed ID: 16874924
    [No Abstract]   [Full Text] [Related]  

  • 7. Elimination of onchocerciasis in Africa by 2025: the need for a broad perspective.
    Cupp E; Sauerbrey M; Cama V; Eberhard M; Lammie PJ; Unnasch TR
    Infect Dis Poverty; 2019 Jul; 8(1):50. PubMed ID: 31303176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elimination of human onchocerciasis: history of progress and current feasibility using ivermectin (Mectizan(®)) monotherapy.
    Cupp EW; Sauerbrey M; Richards F
    Acta Trop; 2011 Sep; 120 Suppl 1():S100-8. PubMed ID: 20801094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The positive influence the Onchocerciasis Elimination Program for the Americas has had on Africa programs.
    Richards FO; Nwoke BEB; Zarroug I; Tukahebwa E; Negussu N; Higazi TB; Oguttu D; Tadesse Z; Miri E; Aziz N; Habomugisha P; Katabarwa M
    Infect Dis Poverty; 2019 Jul; 8(1):52. PubMed ID: 31303175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrofilaricidal Efficacy of Repeated Doses of Ivermectin for the Treatment of River Blindness.
    Walker M; Pion SDS; Fang H; Gardon J; Kamgno J; Basáñez MG; Boussinesq M
    Clin Infect Dis; 2017 Nov; 65(12):2026-2034. PubMed ID: 29020189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The NGDO Co-ordination Group for Onchocerciasis Control.
    Haddad D
    Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():35-8. PubMed ID: 18718153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mectizan and onchocerciasis: 10 years of Mectizan in Africa, a partnership for prolonged success].
    Pacqué M
    Sante; 1998; 8(1):77-8. PubMed ID: 9592889
    [No Abstract]   [Full Text] [Related]  

  • 13. Elimination of onchocerciasis from Colombia: first proof of concept of river blindness elimination in the world.
    Nicholls RS; Duque S; Olaya LA; López MC; Sánchez SB; Morales AL; Palma GI
    Parasit Vectors; 2018 Apr; 11(1):237. PubMed ID: 29642939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study.
    Osei-Atweneboana MY; Eng JK; Boakye DA; Gyapong JO; Prichard RK
    Lancet; 2007 Jun; 369(9578):2021-2029. PubMed ID: 17574093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mectizan as a stimulus for development of novel partnerships: the international organization's perspective.
    Etya'alé DE
    Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S73-7. PubMed ID: 9861271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The World Bank.
    Bangoura O
    Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():31-3. PubMed ID: 18718152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contribution of mectizan to the control of onchocerciasis. Impact on ocular lesions].
    Resnikoff S
    Sante; 1998; 8(1):12-4. PubMed ID: 9592869
    [No Abstract]   [Full Text] [Related]  

  • 18. One in the eye for river blindness.
    Taylor M
    Trends Parasitol; 2001 Aug; 17(8):358. PubMed ID: 11685890
    [No Abstract]   [Full Text] [Related]  

  • 19. The need for evidence-based strategies and tools for onchocerciasis elimination in Africa.
    Dadzie Y; Amazigo UV; Boatin BA; Sékétéli A
    Infect Dis Poverty; 2019 Jul; 8(1):62. PubMed ID: 31303174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. African Programme for Onchocerciasis Control: meeting of National Onchocerciasis Task Forces, September 2012.
    Wkly Epidemiol Rec; 2012 Dec; 87(49/50):494-502. PubMed ID: 23311005
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.